Janus Henderson Group
ELVN icon

Janus Henderson Group’s Enliven Therapeutics ELVN Stock Holding History

Janus Henderson Group’s Portfolio ELVN Stock Details ELVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$431K Sell
11,000
-1,660,724
-99% -$46M ﹤0.01% 2081
2025
Q4 		$25.7M Sell
1,671,724
-121,859
-7% -$2.43M 0.01% 553
2025
Q3 		$36.7M Buy
1,793,583
+77,171
+4% +$1.56M 0.02% 476
2025
Q2 		$34.4M Buy
1,716,412
+145,909
+9% +$2.76M 0.02% 463
2025
Q1 		$33.1M Buy
1,570,503
+238,626
+18% +$5.14M 0.02% 452
2024
Q4 		$30M Buy
1,331,877
+290,153
+28% +$7.52M 0.02% 504
2024
Q3 		$26.6M Buy
1,041,724
+313,019
+43% +$7.25M 0.01% 517
2024
Q2 		$17M Buy
728,705
+14,794
+2% +$311K 0.01% 598
2024
Q1 		$12.6M Buy
713,911
+305,397
+75% +$4.69M 0.01% 647
2023
Q4 		$5.68M Buy
408,514
+132,098
+48% +$1.62M ﹤0.01% 786
2023
Q3 		$3.77M Sell
276,416
-94,578
-25% -$1.59M ﹤0.01% 900
2023
Q2 		$7.57M Sell
370,994
-231,160
-38% -$4.67M ﹤0.01% 745
2023
Q1 		$13.2M Buy
602,154
+369,977
+159% +$7.53M 0.01% 658
2022
Q4 		$3.77M Buy
+232,177
New +$3.71M ﹤0.01% 925

Other funds holding ELVN

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return